colforsin has been researched along with Chronic Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimminger, F; Hansen, T; Krämer, HJ; Rössig, R; Schmehl, T; Schütte, H; Seeger, W; Suttorp, N; Walmrath, D; Weissmann, N | 1 |
| Barnard, J; Haynes, J; Seibert, AF; Taylor, A; Thompson, WJ; Wilborn, WH | 1 |
| Adkins, WK; Barnard, JW; Haynes, J; May, S; Seibert, AF; Taylor, AE | 1 |
3 other study(ies) available for colforsin and Chronic Lung Injury
| Article | Year |
|---|---|
Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibition.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Capillary Permeability; Colforsin; Endothelium, Vascular; Epithelium; Female; Hydrogen Peroxide; In Vitro Techniques; L-Lactate Dehydrogenase; Lung; Lung Injury; Male; Perfusion; Permeability; Phosphodiesterase Inhibitors; Potassium; Pulmonary Circulation; Pyridazines; Rabbits | 1995 |
Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
Topics: Animals; Bucladesine; Capillary Permeability; Colforsin; Cyclic AMP; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Male; Perfusion; Pulmonary Circulation; Rats; Reperfusion Injury | 1992 |
Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury.
Topics: Animals; Bucladesine; Capillaries; Capillary Permeability; Colforsin; Cyclic AMP; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Rabbits; Reperfusion Injury; Vascular Resistance | 1992 |